Product
RSN0402
1 clinical trial
4 indications
Indication
Idiopathic Pulmonary FibrosisIndication
Lung DiseaseIndication
InterstitialIndication
FibrosisClinical trial
A Phase 1, Randomized, Double Blinded, Placebo Controlled, First-in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of RSN0402 in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2024-12-27